Which patient scenario would trigger broader-spectrum empiric coverage for pneumonia?

• A. Hospital-acquired pneumonia or ventilator-associated pneumonia.
• B. Community-acquired pneumonia in a healthy adult.
• C. CAP with no risk factors.
• D. Outpatient pneumonia treated with doxycycline.

Answer: (A)

The key idea is that the setting of pneumonia guides how broad the initial empiric antibiotics should be. In the hospital—especially for pneumonia that starts after 48 hours of admission or occurs in a ventilated patient—the likelihood of multidrug-resistant organisms (like MRSA and Pseudomonas) is much higher. Because you don’t yet know the exact bug, you start with a wider net to cover these resistant pathogens, often pairing an anti-pseudomonal agent with MRSA activity and choosing regimens based on local resistance patterns. De-escalation is then used once culture data return and the patient improves.

In contrast, community-acquired pneumonia in a healthy adult is usually caused by organisms with lower resistance risk, so narrower empiric therapy is appropriate, targeting the common community pathogens. CAP with risk factors or comorbidities may require broader coverage than healthy CAP, but still not to the same extent as hospital-acquired cases. Outpatient pneumonia treated with doxycycline reflects a straightforward, mild case where broad-spectrum coverage isn’t necessary.

So, the scenario that calls for broader-spectrum empiric coverage is hospital-acquired pneumonia or ventilator-associated pneumonia.